BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 15004173)

  • 1. Lipopolysaccharide from Coxiella burnetii is involved in bacterial phagocytosis, filamentous actin reorganization, and inflammatory responses through Toll-like receptor 4.
    Honstettre A; Ghigo E; Moynault A; Capo C; Toman R; Akira S; Takeuchi O; Lepidi H; Raoult D; Mege JL
    J Immunol; 2004 Mar; 172(6):3695-703. PubMed ID: 15004173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of toll-like receptor 2 by Coxiella burnetii is required for macrophage production of pro-inflammatory cytokines and resistance to infection.
    Zamboni DS; Campos MA; Torrecilhas AC; Kiss K; Samuel JE; Golenbock DT; Lauw FN; Roy CR; Almeida IC; Gazzinelli RT
    J Biol Chem; 2004 Dec; 279(52):54405-15. PubMed ID: 15485838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuated Coxiella burnetii phase II causes a febrile response in gamma interferon knockout and Toll-like receptor 2 knockout mice and protects against reinfection.
    Ochoa-Repáraz J; Sentissi J; Trunkle T; Riccardi C; Pascual DW
    Infect Immun; 2007 Dec; 75(12):5845-58. PubMed ID: 17893129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR2 is necessary to inflammatory response in Coxiella burnetii infection.
    Meghari S; Honstettre A; Lepidi H; Ryffel B; Raoult D; Mege JL
    Ann N Y Acad Sci; 2005 Dec; 1063():161-6. PubMed ID: 16481508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coxiella burnetii avoids macrophage phagocytosis by interfering with spatial distribution of complement receptor 3.
    Capo C; Moynault A; Collette Y; Olive D; Brown EJ; Raoult D; Mege JL
    J Immunol; 2003 Apr; 170(8):4217-25. PubMed ID: 12682255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virulent Coxiella burnetii does not activate human dendritic cells: role of lipopolysaccharide as a shielding molecule.
    Shannon JG; Howe D; Heinzen RA
    Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8722-7. PubMed ID: 15939879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coxiella burnetii Lipopolysaccharide: What Do We Know?
    Abnave P; Muracciole X; Ghigo E
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29168790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coxiella burnetii survival in THP-1 monocytes involves the impairment of phagosome maturation: IFN-gamma mediates its restoration and bacterial killing.
    Ghigo E; Capo C; Tung CH; Raoult D; Gorvel JP; Mege JL
    J Immunol; 2002 Oct; 169(8):4488-95. PubMed ID: 12370385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vanin-1 controls granuloma formation and macrophage polarization in Coxiella burnetii infection.
    Meghari S; Berruyer C; Lepidi H; Galland F; Naquet P; Mege JL
    Eur J Immunol; 2007 Jan; 37(1):24-32. PubMed ID: 17163446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular life of Coxiella burnetii in macrophages.
    Ghigo E; Pretat L; Desnues B; Capo C; Raoult D; Mege JL
    Ann N Y Acad Sci; 2009 May; 1166():55-66. PubMed ID: 19538264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection.
    Darville T; O'Neill JM; Andrews CW; Nagarajan UM; Stahl L; Ojcius DM
    J Immunol; 2003 Dec; 171(11):6187-97. PubMed ID: 14634135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbicidal property of B1 cell derived mononuclear phagocyte.
    Popi AF; Zamboni DS; Mortara RA; Mariano M
    Immunobiology; 2009; 214(8):664-73. PubMed ID: 19321225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor 4 dependence of innate and adaptive immunity to Salmonella: importance of the Kupffer cell network.
    Vazquez-Torres A; Vallance BA; Bergman MA; Finlay BB; Cookson BT; Jones-Carson J; Fang FC
    J Immunol; 2004 May; 172(10):6202-8. PubMed ID: 15128808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular activation, phagocytosis, and bactericidal activity against group B streptococcus involve parallel myeloid differentiation factor 88-dependent and independent signaling pathways.
    Henneke P; Takeuchi O; Malley R; Lien E; Ingalls RR; Freeman MW; Mayadas T; Nizet V; Akira S; Kasper DL; Golenbock DT
    J Immunol; 2002 Oct; 169(7):3970-7. PubMed ID: 12244198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Both inducible nitric oxide synthase and NADPH oxidase contribute to the control of virulent phase I Coxiella burnetii infections.
    Brennan RE; Russell K; Zhang G; Samuel JE
    Infect Immun; 2004 Nov; 72(11):6666-75. PubMed ID: 15501800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coxiella burnetii survives in monocytes from patients with Q fever endocarditis: involvement of tumor necrosis factor.
    Dellacasagrande J; Ghigo E; Capo C; Raoult D; Mege JL
    Infect Immun; 2000 Jan; 68(1):160-4. PubMed ID: 10603382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inositol 3-phosphatase PTEN negatively regulates Fc gamma receptor signaling, but supports Toll-like receptor 4 signaling in murine peritoneal macrophages.
    Cao X; Wei G; Fang H; Guo J; Weinstein M; Marsh CB; Ostrowski MC; Tridandapani S
    J Immunol; 2004 Apr; 172(8):4851-7. PubMed ID: 15067063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis.
    Netea MG; Van Der Graaf CA; Vonk AG; Verschueren I; Van Der Meer JW; Kullberg BJ
    J Infect Dis; 2002 May; 185(10):1483-9. PubMed ID: 11992285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular bacterial infection-induced IFN-gamma is critically but not solely dependent on Toll-like receptor 4-myeloid differentiation factor 88-IFN-alpha beta-STAT1 signaling.
    Rothfuchs AG; Trumstedt C; Wigzell H; Rottenberg ME
    J Immunol; 2004 May; 172(10):6345-53. PubMed ID: 15128825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dominant role of Toll-like receptor 4 in the signaling of apoptosis in bacteria-faced macrophages.
    Haase R; Kirschning CJ; Sing A; Schröttner P; Fukase K; Kusumoto S; Wagner H; Heesemann J; Ruckdeschel K
    J Immunol; 2003 Oct; 171(8):4294-303. PubMed ID: 14530354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.